Highly effective current treatments for vision loss need to be allied with careful counselling to ensure patients maintain good psychological health as well as good vision, new research recommends.
MANILA, Philippines - Having poor eyesight is common in older people but severe loss of vision and even blindness can set in for individuals as early as age 55. One of the leading reasons why elderly ...
KUWAIT CITY, Apr 7: Kuwait International Bank (KIB) reaffirmed its commitment to enhancing banking awareness among its customers, as part of the “Let’s Be Aware” (Diraya) campaign, launched by the ...
KUWAIT CITY, May 28, (BUSINESS WIRE): ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, and KNET, Kuwait’s national electronic banking company, today announced that ...
Highly effective current treatments for vision loss need to be allied with careful counselling to ensure patients maintain good psychological health as well as good vision, new research recommends.
Clinical Trials Arena on MSN
Ollin Biosciences secures $330m to fund phase III OLN324 trials
The global Phase III trials of OLN324 in DME and wAMD will be launched in the second half of 2026.
Ollin Biosciences’ VEGF/Ang2 bispecific antibody has shown superiority over Roche’s Vabysmo (faricimab) in a head-to-head trial in diabetic macular oedema (DME) or wet (neovascular) age-related ...
Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, announced final 20-week study completion data from its randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results